About Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation is primarily a biomedical research funder that supports investigator-initiated and translational research on inflammatory bowel disease by channeling multi-year and project grants to leading academic medical centers, pediatric hospitals, and specialized biotech partners. Its portfolio concentrates on clinical and translational studies, biomarker and therapeutic development, and pediatric IBD research, frequently supporting the same top research institutions repeatedly rather than broad community programming.
Focus Areas
Clinical and translational IBD research at major academic medical centers (e.g., Cornell, Mount Sinai, UCLA)Pediatric inflammatory bowel disease research and care (e.g., Boston Children's, Cincinnati Children's)Therapeutic development and biomarker/real-world evidence partnerships with biotech firms (e.g., Aetion, Enlisenese, Infinity Biologix)Multi-site investigator-initiated studies and clinical trials infrastructureCenter-level or institutional research support for top university medical centers
Who They Fund
children with Crohn's disease or ulcerative colitis
About Crohn's & Colitis Foundation
Crohn's & Colitis Foundation Inc. directs its grantmaking toward biomedical research on inflammatory bowel disease, with large awards flowing to academic medical centers, pediatric hospitals, and biotech partners. In the recent grants list, Weill Medical College of Cornell University received $926,360 in 2024 and $588,047 in 2023, showing repeat support for the same research institution. Other major awards went to Cincinnati Children's Hospital Medical Center for research and to Icahn School of Medicine at Mount Sinai, both part of a pattern of funding university-based clinical and translational work. The foundation also backs specialized industry collaborators such as Infinity Biologix LLC and Enlisense LLC, alongside established medical centers including Cedars Sinai Medical Center, Cleveland Clinic Foundation, and Washington University in St Louis. The overall picture is a funder that uses sizeable project grants to support investigator-initiated studies, biomarker and therapeutic development, and research infrastructure across a national network of IBD research institutions. Its giving is concentrated in the research ecosystem rather than broad community programming, and the same institutions appear repeatedly across multiple years.
What Crohn's & Colitis Foundation Funds
Clinical and translational IBD research is a central theme. The foundation gave $1,017,114 in 2023 to Vanderbilt University Medical Center for research, and $692,063 in 2023 to The Regents of the University of California Los Angeles for research. Pediatric inflammatory bowel disease is another clear area: Boston Children's Hospital received $539,217 in 2024, and Cincinnati Children's Hospital Medical Center received $815,000 in 2024, both for research. The funder also supports therapeutic and biomarker development through specialized partners, including $661,903 in 2025 to Infinity Biologix LLC and $450,000 in 2024 to Enlisense LLC. Its portfolio includes multi-site academic research as well, with awards to The University of North Carolina at Chapel Hill, Case Western Reserve University - School of Medicine, and University of Maryland Baltimore.
How Crohn's & Colitis Foundation Gives
Typical awards are mid-six figures: p25 is $57,910, median is $115,830, and p75 is $299,182. The recent list also shows repeated support for the same institutions across years, including Weill Medical College of Cornell University, Cedars Sinai Medical Center, Washington University in St Louis, University of Maryland Baltimore, and The Regents of the University of Michigan. That pattern fits a regular funder rather than a donor-advised vehicle. The foundation does not fund individuals and does not make program-related investments. Recent grants are all research grants, suggesting a project-oriented approach tied to institutional research activity rather than open application philanthropy.
Financial Snapshot
Annual Giving
$13M
Total Assets
$50.6M
Total Revenue
$85.2M
Total Expenses
$83.5M
Typical Grant Size
Most grants fall between $58K and $299K, with a median of $116K.
25th Percentile
$58K
Median
$116K
75th Percentile
$299K
Geographic Reach
National31 states funded
About 10% of grants go to recipients in CA.
Funding intensity
LowHigh
Headquarters
Leadership
MICHAEL OSSO
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Crohn's & Colitis Foundation?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime